Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31

Agency: VETERANS AFFAIRS, DEPARTMENT OF
State: Federal
Type of Government: Federal
FSC Category:
  • Q - Medical Services
NAICS Category:
  • 621511 - Medical Laboratories
Posted Date: Jul 2, 2026
Due Date: Jul 10, 2026
Solicitation No: 36C26026Q0807
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Active
Contract Opportunity
Notice ID
36C26026Q0807
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
260-NETWORK CONTRACT OFFICE 20 (36C260)
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • Original Published Date: Jul 02, 2026 11:49 am PDT
  • Original Response Date: Jul 10, 2026 10:00 am PDT
  • Inactive Policy: Manual
  • Original Inactive Date: Jul 25, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: Q301 - REFERENCE LABORATORY TESTING
  • NAICS Code:
    • 621511 - Medical Laboratories
  • Place of Performance:
    Portland VAMC 3710 NW US Veterans Hospital Road Portland , 97239
Description
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).
Attachments/Links
Contact Information
Contracting Office Address
  • 1601 E Fourth Plain Blvd Bldg 17 Suite B428
  • VANCOUVER , WA 98661
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Jul 2, 2026[Solicitation (Original)] Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.
View Sample Report Start Free Trial

See Also

Q402--Q402- Atlanta VAMC Comm...

Follow Q402--Q402- Atlanta VAMC Community Nursing Home Services Active Contract Opportunity Notice ID

VETERANS AFFAIRS, DEPARTMENT OF

Due by 9/30/2027

Q--Sources Sought for analyti...

Follow Q--Sources Sought for analytical method validation study Active Contract Opportunity Notice ID

INTERIOR, DEPARTMENT OF THE

Due by 9/15/2026

Cryo-Electron Microscopy (Cry...

Follow Cryo-Electron Microscopy (Cryo-EM) Services Active Contract Opportunity Notice ID 75N98026Q01177 Related Notice

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Due by 9/16/2026

VCU HEART AND RENAL LAB AND T...

Follow VCU HEART AND RENAL LAB AND TRANSPLANT TESTING Active Contract Opportunity Notice

VETERANS AFFAIRS, DEPARTMENT OF

Due by 9/21/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.